NDC 70518-0597-2 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0597
- Requested NDC
- 70518-0597-2
- Package NDCs from labels
- 70518-0597-0, 70518-0597-2, 70518-0597-1, 70518-0597-3
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-01-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide Tablets, USP Rx only | REMEDYREPACK INC. | 2024-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2b94985-c79d-40e3-e053-2a95a90a0d78 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c97e38f2-7163-4d4e-a694-4d0612423e53 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2f3b60a-bffe-2675-e053-2995a90ae96e | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f7091c54-0984-7f6e-e053-6394a90afb4d | 2026-01-01 | Warnings, Adverse reactions | ANDA083177 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f68d211d-d802-6c78-e053-2995a90a90d7 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3984e6b9-2d88-47f0-af09-cce428bba14f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db895e64-3f97-9201-e053-2a95a90ac7ef | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | bdca31d3-60b1-4659-aef7-56530b4f9039 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | bc8b9ae2-8263-4624-8629-4f856392f9da | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | deafd195-7a1b-4ad8-a371-2cd9f433dea5 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 076017ce-8aad-1336-e063-6394a90a76b5 | 2025-12-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 08f3885e-dfde-79e4-e063-6394a90a4c09 | 2025-12-26 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | acecced9-2a61-435d-b7d4-b151cb7b7e5d | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ATACAND HCT | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | d91152c4-66ba-466f-b4f9-0da628d42b1d | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | bd8d318d-167a-4b26-935d-265dde3193de | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | QPharma, Inc. | c80b2164-3795-6668-e053-2a95a90a4d45 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 466dd0d2-9815-4c3e-b66b-d0732b3ba8e9 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | 181324c5-256f-4570-a0bb-8bc908deb2e2 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f9faec8a-2b71-47bb-a296-48ecbce9af50 | 2025-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | c9c44c37-bb49-4364-9293-3c8fd51b759e | 2025-12-16 | Warnings, Adverse reactions | ANDA083177 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.